Rebecca Hanna

Dr. Rebecca Hanna is a Clinical Research Fellow at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health. Her research focuses on cardiovascular health, hypertension, and metabolic disorders, with an emphasis on clinical trials and translational medicine. She has contributed to studies evaluating novel therapies like supersaturated oxygen therapy and investigating long-term cardiovascular impacts of SARS-CoV-2 infection. Her work also explores patient empowerment strategies through digital health tools, such as the Kvatchii platform for home blood pressure monitoring. Dr. Hanna’s recent studies highlight interdisciplinary approaches to understanding genetic influences on hypertension and optimizing post-intervention cardiac care.

Research Interests: Dr. Hanna’s interests span cardiovascular disease mechanisms, hypertension pathophysiology, and the application of telemedicine in chronic disease management. She is particularly invested in post-MI (myocardial infarction) therapies and the vascular consequences of viral infections. Her work often bridges clinical practice and basic science, aiming to improve patient outcomes through evidence-based interventions.

Grants & Advising: While specific grant details are not listed, her involvement in the OPTIMA-BP protocol indicates participation in funded studies. No formal advisees are noted in the provided data.

Labs/Teams: Collaborates within the School of Cardiovascular & Metabolic Health on multidisciplinary projects addressing cardiovascular and metabolic health challenges.